GLP-1RA significantly reduces dementia and cognitive impairment in diabetic patients: JAMA Jacinthlyn Sylvia10 April 2025 6:15 AM ISTA new study published in the Journal of American Medical Association showed that glucagon-like peptide-1 receptor agonists (GLP-1RAs)-based...
GLP1 Receptor Agonists reduce VTE risk in Type 2 Diabetes, claims research Dr.Niharika Harsha B25 Nov 2024 9:15 AM ISTA recent groundbreaking study found that Glucagon-like peptide 1 receptor agonists (GLP1-RA) are effective in reducing venous thromboembolism (VTE)...
Antidiabetic Drugs Linked to Reduced Asthma Attacks: Study Highlights Synergistic Benefits of Metformin and GLP-1RA Medha Baranwal22 Nov 2024 9:00 AM ISTUK: A recent cohort study published in JAMA Internal Medicine has revealed that antidiabetic medications, specifically metformin and glucagon-like...
Combining GLP-1 Therapy with FreeStyle Libre Yields Superior Glycemic Control in Type 2 Diabetes Patients: Study Medha Baranwal9 Nov 2024 8:00 AM ISTUSA: A recent study published in Diabetes Technology & Therapeutics has highlighted the advantages of integrating FreeStyle Libre continuous...
Bariatric surgery imore cost effective than newer weight loss drugs alone, finds study Dr. Kamal Kant Kohli7 Nov 2024 9:45 PM ISTNewer weight loss drugs are cost effective in the long term only when combined with bariatric weight loss surgery, according to a study presented at...
GLP-1 Receptor Agonists May Elevate Levels of Tumor Marker CA 19-9: A Cautionary Case Study Medha Baranwal6 Nov 2024 9:00 AM ISTChina: Recent observations have highlighted a rare and noteworthy side effect associated with the use of glucagon-like peptide-1 (GLP-1) receptor...
GLP-1 RAs Superior to Metformin for Blood Sugar Control, Yet Metformin Shows Higher Adherence in Prediabetes: Study Medha Baranwal19 Oct 2024 9:00 AM ISTDenmark: A recent nationwide cohort study has shed light on the effectiveness of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) compared to...
SGLT2 inhibitors and GLP1 receptor agonists combo tied to additional heart and kidney benefits: Lancet Dr. Kamal Kant Kohli9 July 2024 8:15 PM ISTNew research shows combined use of sodium glucose co-transporter 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP1-RAs) is...
Switching to tirzepatide from GLP-1 RAs shows promise in diabetes treatment, unravels study Medha Baranwal12 Jun 2024 10:00 AM ISTUSA: In the realm of diabetes management, a significant shift is underway with the emergence of tirzepatide as a potential game-changer. A recent...
Bariatric surgery tied to lower mortality versus GLP-1 receptor agonists if diabetes duration is 10 years or less: JAMA Medha Baranwal11 Jun 2024 10:00 AM ISTIsrael: In the realm of metabolic disorders and obesity management, two prominent interventions have emerged as frontrunners: Bariatric Metabolic...
GLP-1 receptor agonists use in youth with type 2 diabetes tied to decreased HbA1c levels: Study Medha Baranwal19 March 2024 9:30 PM ISTUSA: Real-world use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) in children and adults between the ages of 11 and 23 with type 2 diabetes...
GLP-1 RA linked to significant gastric contents before anaesthesia and increased risk of aspiration: JAMA Dr. Kamal Kant Kohli8 March 2024 12:45 AM ISTSafety concerns for patients undergoing anesthesia who use glucagon-like peptide-1 receptor agonists (GLP-1 RAs), which are medications approved for...
